Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β
Marina Ostroukhova, … , rabir Ray,, Anuradha Ray
Marina Ostroukhova, … , rabir Ray,, Anuradha Ray
Published April 3, 2006
Citation Information: J Clin Invest. 2006;116(4):996-1004. https://doi.org/10.1172/JCI26490.
View: Text | PDF
Research Article Immunology

Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β

  • Text
  • PDF
Abstract

Studies in humans and mice show an important role for Tregs in the control of immunological disorders. The mechanisms underlying the immunosuppressive functions of Tregs are not well understood. Here, we show that CD4+ T cells expressing Foxp3 and membrane-bound TGF-β (TGF-βm+Foxp3+), previously shown to be immunosuppressive in both allergic and autoimmune diseases, activate the Notch1–hairy and enhancer of split 1 (Notch1-HES1) axis in target cells. Soluble TGF-β and cells secreting similar levels of soluble TGF-β were unable to trigger Notch1 activation. Inhibition of Notch1 activation in vivo reversed the immunosuppressive functions of TGF-βm+Foxp3+ cells, resulting in severe allergic airway inflammation. Integration of the TGF-β and Notch1 pathways may be an important mechanism for the maintenance of immune homeostasis in the periphery.

Authors

Marina Ostroukhova, Zengbiao Qi, Timothy B. Oriss, Barbara Dixon-McCarthy, rabir Ray,, Anuradha Ray

×

Figure 2

Upregulation of Notch1 on target cells by TGF-βm+ but not by TGF-βm– cells.

Options: View larger image (or click on image) Download as PowerPoint
Upregulation of Notch1 on target cells by TGF-βm+ but not by TGF-βm– cel...
(A) Post-sort TGF-β flow cytometry profile of TGF-βm+ and TGF-βm– cells. TGF-βm+ cells were induced in mice using the tolerance protocol. On day 21, CD4+ T cells were prepared by negative selection, and cells expressing TGF-β on the cell surface (TGF-βm+) were separated from those devoid of cell surface TGF-β (TGF-βm–) using 2 rounds of sorting. The purity of the 2 populations was assessed by flow cytometry (~80% enrichment of TGF-βm+ cells). (B) Experimental strategy. TGF-βm+ or TGF-βm– cells were mixed with DO11.10 TCR transgenic CD4+ T cells (target cells) in a 1:1 ratio and stimulated in vitro with whole OVA protein and APCs. (C) Staining with anti-Notch1 and KJ1-26 antibody or matching isotype control of an aliquot of 105 total cells removed after 48 hours of incubation. Each dot plot contains approximately 1,000 events. Numbers in dot plots denote percentages. (D) Western blot analysis of the presence of cleaved Notch1 in total cell extracts (TCEs) prepared from the mixed cultures after 24 hours of incubation using antibody specific to cleaved Notch1. Expression of β-actin is shown as a marker for protein loading. (E) Analysis of HES1 expression by immunoblotting of nuclear extracts (NEs) prepared after 72 hours of culture. CREB-1 expression was examined to assess protein loading. Results shown are representative of 2 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts